All of us began life as a bundle of stem cells. This was in our embryonic existence. Soon these stem cells grew into specialized groups of tissues which resulted in organs and limbs, forming out complex human bodies. A few of them remained as stem cells. For instance bone marrow is a rich source of adult stem cells. Stem cell research has become a hot topic in medical science research for two reasons; they can, if grown in a laboratory, form a healthy replacement for diseased tissue cells in a patient. The easiest source of stem cells however is from an embryo, such as found in an aborted foetus, thus embryos are of scientific value. This is controversial to the new political Right and became a major issue in the recently concluded U.S. presidential elections. Some of George Bush's campaigners called for a ban on all stem cell research using human embryos. There are, however, two other ways of obtaining stem cells: from adult sources rich in stem cells such as bone marrow or by what is known as therapeutic cloning. The latter is to take some diseased cells from a patient, and reverse it to its primordial state similar to a fertilized egg and then persuade i t to grow back into a n embryonic stage, and subsequently divide into different tissues. The resulting grown cells would be healthy and not rejected by the patient when reintroduced. Adult stem cell research however is nascent and has not progressed beyond the Petri dish in a laboratory.
Abuljadayel, an Indian -Muslim woman scientist's approach was unique, similar to the therapeutic method, but she has progressed to the stage of treating real life patients. Her initial discovery was accidental while working in a University of Sri Lanka, Nugegoda. hospital in Jeddah and doing 'part time' research. She made a solution of leukemia cells and attached an antibody termed CR3143 to bind on to these cells. The solution also had immune molecules called a complement which destroy any cells with attached CR3143 antibodies. In one instance however, she forgot to include the complement. The leukemia cells, instead of dying, had visibly changed and looked very much like bone marrow stem cells. She repeated the experiment without the complement several times, and found that repeatedly the diseased cells were regressing into their stem cells; a retrodifferentiation, which was pure biological heresy. Somehow it appeared that the specialized adult leukemia cell regressed back into its original stem cell form when a CR3143 antibody was attached to it. Importantly, the new immune cells which grew from these stem cells in the human body were healthy. As the leukemia cells were taken from a patient and treated, the stem cells could be reinserted without rejection. Further, no embryonic source, hence no controversy. Sanjay, a young man with A-plastic anemia was marvelously cured by such a process, in a Mumbai Hospital. I t is now routinely practiced by Abuljadayel a n d h e r team, on other life threatening diseases as well.
Her first experiments at Jeddah were in 1990. She tried to publish, but was rejected repeatedly. Meanwhile in 1997, Dolly the cloned sheep arrived in Edinburgh, she was produced by regressed adult cell nucleus. Still she could not publish. Meanwhile, she continued her research in India. She look a patent out in 1994 on the process and her husband raised funds by forming a company called Tri-stem. Using these funds she worked in India, and furthered her research. She now claims that she could develop any tissue typeneurons, mussels, heart etc. from embryonic type stem cells by this procedure of obtaining adult cells, diseased or healthy, regressing them back to their original stem cells and re-growing them back by using growth factors. Amazing good news, for those with diseased cells. All that has not been tested so far is whether this approach results in Abuljadayel and her husband had to use permanent cures, because the cured patients are unusual sources of funds such as tapping the too recent. Only time will tell, but so far so good.
British stock-market. This raises questions as to how science funding reinforces orthodoxy, and Finally in 2003, her work was accepted constraints any radical shifts in its research for publication in a peer reviewed journal, thirteen programme. years since her accidental discovery. Why did it take so long, and why are other researchers not Finally Abuljadayel's work by -passes the repeating her work? Why didn't her outstanding ethics controversy in stem-cell research as it does work result in a research programme i n a not require the use of cells, from an aborted foetus. Lakotosian sense, perhaps to surpass her or even This is a big issue in Judeo-Christian societies to refute her? These are awkward questions which but should it be for other cultures? We in Sri raise socio-political issues about today's science.
Lanka have been playing the role of a scientific foot soldier, taking commands from those Centres
The fact t h a t she is a woman from a of Science in Europe and America's. Abuljadayel's country well outside the 'Centres of excellence' of pioneering work should teach us to take control today's science may have something to do with and chart out our own scientific pathways. The this. Dolly the Sheep, was accepted, published and Indians have already begun to do so. repeated in many other AmericanIEuropean Laboratories almost immediately, a t least since publication.
